--- title: Raji CDX Model - TD2 Precision Oncology description: Raji serves as a central cell line for research on Burkitt's lymphoma, illuminating the disease's unique genetic and molecular attributes and guiding therapeutic advancements. image: https://td2inc.com/hubfs/Assets/GraphsFigures/raji.jpg --- ×   [![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en) ![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png) [![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en) ![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png) # Raji CDX Model The Raji cell line is derived from human Burkitt’s lymphoma, a highly aggressive B-cell non-Hodgkin lymphoma known for its association with the Epstein-Barr virus (EBV). Burkitt’s lymphoma is characterized by its translocation involving the MYC gene and its rapid tumor growth. The Raji cell line provides a quintessential platform for understanding the intricate biology, progression, and therapeutic challenges associated with Burkitt’s lymphoma. Representing key molecular features and genetic alterations, including the EBV positivity and MYC translocation, Raji holds significant relevance in preclinical lymphoma studies. The in vitro and in vivo behavior of Raji offers insights into the aggressive growth kinetics, metabolic activity, and therapeutic responsiveness of Burkitt’s tumors. Researchers utilize the Raji model extensively to dissect the molecular underpinnings of Burkitt’s lymphoma, evaluate novel therapeutic agents, and understand potential resistance mechanisms to current treatments. ## Model Details **Cancer Location:** Lymphoid **Cancer Type:** Burkitt’s Lymphoma **Model Name:** Raji **Mouse Strain:** SCID-Beige, NSG **Treatment Data Available:** Chemotherapy (Rituximab) ## Raji Growth Curves ![Raji CDX Model](https://td2inc.com/hubfs/Assets/GraphsFigures/raji.jpg) Growth of subcutaneous Raji in SCID-Beige mice (n=5 mice). ### Request Additional CDX Model Data ## CONTACT US ## Get Started. Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started. [Get Started Now](https://td2inc.com/contact-us/?hsLang=en) [![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en) Office 13208 E. Shea Blvd, Suite 100 Scottsdale, AZ 85259 Phone (602) 358-8300 Connect with us - - ![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png) © 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)